CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for PPD Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

PPD Inc
929 North Front Street
Phone: (910) 251-0081p:910 251-0081 WILMINGTON, NC  28401-3331  United States

This company was Merged or Acquired on 12/8/2021.
This company ceased filing statements with the SEC on 12/20/2021.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
PPD, Inc. is a provider of drug development services to the biopharmaceutical industry. The Company provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. The Company operates through two segments: Clinical Development Services and Laboratory Services. The Clinical Development Services segment provides a range of services to its customers including early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment provides services to its customers including bioanalytical, vaccine sciences, good manufacturing practice (GMP), central lab and biomarker testing.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202112/31/2020YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research
8071 Medical laboratories

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer David S.Simmons 56 5/1/2012 5/1/2012
Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary Christopher G.Scully 50 5/1/2018 5/1/2018
Chief Operating Officer William J.Sharbaugh 58 4/1/2007 4/1/2007
12 additional Officers and Directors records available in full report.

Business Names
Business Name
0972792 B.C. LTD
AbC.R.O., Inc.
Access to Patients, LLC
142 additional Business Names available in full report.

General Information
Number of Employees: 26,000 (As of 12/31/2020)
Outstanding Shares: 351,394,547 (As of 10/25/2021)
Shareholders: 60
Stock Exchange: NASD
Federal Tax Id: 453806427


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, July 4, 2024